Prognostic evaluation of interim PET negative DLBCL patients: Can baseline and interim PET imaging with clinical indicators offer additional value?

被引:0
|
作者
Chen, Xi [1 ]
Sun, Xun [1 ,2 ]
Zhang, Yongxue [1 ]
An, Rui [3 ]
Lan, Xiaoli [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Nucl Med, Wuhan, Peoples R China
[2] Hubei Key Lab Mol Imaging, Wuhan, Peoples R China
[3] HUST, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
241610
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Prognostic role of baseline 18F-FDG PET/CT in DLBCL patients
    Baratto, Lucia
    Wu, Fengyu
    Minamimoto, Ryogo
    Sabile, Jean
    Advani, Ranjana
    Mittra, Erik
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [32] Controversies on the prognostic value of interim FDG-PET in advanced-stage Hodgkin lymphoma
    Adams, Hugo J. A.
    Kwee, Thomas C.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (06) : 491 - 498
  • [33] Prognostic value of interim FDG and FLT PET/CT in diffuse large B cell lymphoma
    Wang, Ruimin
    Zhu, Haiyan
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [34] Evaluate prognostic significance of FDG PET-CT scan derived MTV at staging and comparison with SUV based response evaluation on interim PET-CT in patients with Non Hodgkins lymphoma DLBCL
    Singh, Natasha
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [35] Prognostic values of baseline, interim and end-of therapy 18F-FDG PET/CT in patients with follicular lymphoma
    Zhou, Yeye
    Zhao, Zixuan
    Li, Jihui
    Zhang, Bin
    Sang, Shibiao
    Wu, Yiwei
    Deng, Shengming
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 6871 - 6885
  • [36] Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study
    Luigi Rigacci
    Benedetta Puccini
    Alessandro Broccoli
    Manjola Dona
    Manuel Gotti
    Andrea Evangelista
    Armando Santoro
    Maurizio Bonfichi
    Alessandro Re
    Michele Spina
    Barbara Botto
    Alessandro Pulsoni
    Chiara Pagani
    Caterina Stelitano
    Flavia Salvi
    Luca Nassi
    Lara Mannelli
    Sofia Kovalchuk
    Daniela Gioia
    Pier Luigi Zinzani
    Annals of Hematology, 2020, 99 : 283 - 291
  • [37] Negative Interim PET Consistently Predicts for Better Outcome of DLBCL in an IAEA-Sponsored Multi-national Study
    Paez, D.
    Fanti, S.
    Meneghetti, J. C.
    Gyoerke, T.
    Moneta, F. R.
    Auewarakul, C. U.
    Nair, R.
    Viado-Gorospe, C.
    Kucuk, O.
    Morris, T. P.
    Padua, R. A.
    Cerci, J. J.
    Carr, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S222 - S223
  • [38] Clinical characteristics of interim-PET negative patients with a positive end PET from the prospective HD08-01 FIL study
    Rigacci, Luigi
    Puccini, Benedetta
    Broccoli, Alessandro
    Dona, Manjola
    Gotti, Manuel
    Evangelista, Andrea
    Santoro, Armando
    Bonfichi, Maurizio
    Re, Alessandro
    Spina, Michele
    Botto, Barbara
    Pulsoni, Alessandro
    Pagani, Chiara
    Stelitano, Caterina
    Salvi, Flavia
    Nassi, Luca
    Mannelli, Lara
    Kovalchuk, Sofia
    Gioia, Daniela
    Zinzani, Pier Luigi
    ANNALS OF HEMATOLOGY, 2020, 99 (02) : 283 - 291
  • [39] Quantitative analyses at Baseline and Interim PET evaluation for response assessment and outcome definition in patients with Malignant Pleural Mesothelioma (MPM)
    Lopci, E.
    Zucali, P. A.
    Perrino, M.
    Giordano, L.
    Ceresoli, G. L.
    Gianoncelli, L.
    Lorenzi, E.
    Gemelli, M.
    Santoro, A.
    Chiti, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S249 - S249
  • [40] Prognostic Value of SUV in Interim 18F-FDG PET in Non-Hodgkin's Lymphoma Patients
    Cozar Santiago, M.
    Ferrer Rebolleda, J.
    Vicedo Gonzalez, A.
    Sanz Llorens, R.
    Aguilar Barrios, J.
    Devis Saiz, M.
    Sanchez Jurado, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S376 - S376